Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal Alloimmune Thrombocytopenia

ID#: NCT05345561

Age: 18 years - 66+

Gender: Female

Healthy Subjects: Accepts Healthy Volunteers

Recruitment Status: Recruiting

Start Date: March 14, 2022

End Date: June 01, 2027

Contact Information:
Chief Medical Officer
(203) 859-3820
Summary: A prospective, non-interventional, natural history study to assess the occurrence of higher FNAIT risk across a broad population of different racial and ethnic characteristics and the occurrence of HPA-1a alloimmunization in these women.
Eligibility:

Inclusion Criteria:

- Pregnant women (≥ 18 years of age) who have provided informed consent for the study.

Exclusion Criteria:

- Participants with prior history of FNAIT
Find a Clinical Trial Find Cancer Clinical Trials